Proven <i>Aspergillus flavus</i> pulmonary aspergillosis in a COVID‐19 patient: A case report and review of the literature
Mohammadreza Salehi, Nasim Khajavirad, Arash Seifi, Faeze Salahshour, Behnaz Jahanbin, Hossein Kazemizadeh, Sayed Jamal Hashemi, Seyed Ali Dehghan Manshadi, Mohammad Kord, Paul E. Verweij, Sadegh Khodavaisy
Abstract
Severe COVID-19 patients complicated with aspergillosis are increasingly reported. We present a histopathological proven case of fatal COVID-19-associated pulmonary aspergillosis (CAPA), due to Aspergillus flavus. This report and existing published literature indicate diagnostic challenges and poor outcomes of CAPA in ICU patients.
Topics & Concepts
Pulmonary aspergillosisAspergillus flavusAspergillosisCoronavirus disease 2019 (COVID-19)AspergillusMedicineIntensive care medicinePathologyImmunologyMicrobiologyBiologyInfectious disease (medical specialty)DiseaseAntifungal resistance and susceptibilityFungal Infections and StudiesAntimicrobial Resistance in Staphylococcus